Phio Pharmaceuticals
PHIO
6 hedge funds and large institutions have $285K invested in Phio Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.2% less ownership
Funds ownership: 0.23% → 0.03% (-0.2%)
25% less funds holding
Funds holding: 8 → 6 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
77% less capital invested
Capital invested by funds: $1.25M → $285K (-$960K)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WS
Wedbush Securities
Los Angeles,
California
|
+$74K |
| 2 |
Renaissance Technologies
New York
|
+$73.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$23.5K |
| 4 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
+$479 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$637K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$452K |
| 3 |
JP Morgan Chase
New York
|
-$47.7K |
| 4 |
EDRH
Edmond de Rothschild Holding
Chambesy,
Switzerland
|
-$22K |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$1.92K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $162K | +$73.3K | +306 | +80% |
|
|
WS
2
Wedbush Securities
Los Angeles,
California
| $73K | +$74K | +309 | New |
|
|
3
HSBC Holdings
London,
United Kingdom
| $25K | -$1.92K | -8 | -7% |
|
|
4
UBS Group
Zurich,
Switzerland
| $24K | +$23.5K | +98 | +1,960% |
|
|
VFA
5
Valeo Financial Advisors
Carmel,
Indiana
| $1K | +$479 | +2 | New |
|
|
CH
6
CVI Holdings
Wilmington,
Delaware
| – | -$637K | -3,334 | Closed |
|
|
SM
7
Sabby Management
Miami Beach,
Florida
| – | -$452K | -2,363 | Closed |
|
|
8
JP Morgan Chase
New York
| – | -$47.7K | -199 | -99% |
|
|
EDRH
9
Edmond de Rothschild Holding
Chambesy,
Switzerland
| – | -$22K | -116 | Closed |
|
PHIO Hedge Fund Activity: Q2 2020 in Review
6 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals (PHIO) for Q2 2020, worth a combined $285K — down 77% from $1.25M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PHIO and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Wedbush Securities, opening a new position worth an estimated $74K. The largest seller was CVI Holdings, exiting entirely with an estimated $637K sold.
- 6 institutional investors held Phio Pharmaceuticals (PHIO) as of Q2 2020, down from 8 in Q1 2020.
- Funds reported $285K of Phio Pharmaceuticals stock for Q2 2020, down 77% quarter-over-quarter.
- 2 funds opened new Phio Pharmaceuticals positions in Q2 2020 and 4 closed out, a net change of -2 holders.
- The largest Phio Pharmaceuticals buyer in Q2 2020 was Wedbush Securities, an estimated $74K added.
- The largest Phio Pharmaceuticals seller in Q2 2020 was CVI Holdings, an estimated $637K sold.
Based on aggregated 13F filings for Q2 2020.